CH564563A5 - - Google Patents

Info

Publication number
CH564563A5
CH564563A5 CH116472A CH116472A CH564563A5 CH 564563 A5 CH564563 A5 CH 564563A5 CH 116472 A CH116472 A CH 116472A CH 116472 A CH116472 A CH 116472A CH 564563 A5 CH564563 A5 CH 564563A5
Authority
CH
Switzerland
Application number
CH116472A
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of CH564563A5 publication Critical patent/CH564563A5/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B7/00—Mountings, adjusting means, or light-tight connections, for optical elements
    • G02B7/20—Light-tight connections for movable optical elements
    • G02B7/22—Extensible connections, e.g. bellows
CH116472A 1968-01-19 1969-01-20 CH564563A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3100/68A GB1253831A (en) 1968-01-19 1968-01-19 9alpha,21-DIHALOPREGNANE COMPOUNDS

Publications (1)

Publication Number Publication Date
CH564563A5 true CH564563A5 (xx) 1975-07-31

Family

ID=9751941

Family Applications (2)

Application Number Title Priority Date Filing Date
CH116472A CH564563A5 (xx) 1968-01-19 1969-01-20
CH77569A CH564035A5 (xx) 1959-11-24 1969-01-20

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH77569A CH564035A5 (xx) 1959-11-24 1969-01-20

Country Status (14)

Country Link
US (1) US3721687A (xx)
BE (1) BE727109A (xx)
BR (1) BR6905681D0 (xx)
CA (1) CA952900A (xx)
CH (2) CH564563A5 (xx)
DK (1) DK126500B (xx)
ES (1) ES362679A1 (xx)
FR (1) FR2000443A1 (xx)
GB (1) GB1253831A (xx)
IE (1) IE33204B1 (xx)
IL (1) IL31447A (xx)
NL (1) NL6900795A (xx)
NO (1) NO132100C (xx)
SE (1) SE350035B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
US4044126A (en) * 1972-04-20 1977-08-23 Allen & Hanburys Limited Steroidal aerosol compositions and process for the preparation thereof
US4154748A (en) * 1978-01-20 1979-05-15 The Upjohn Company Phosphate catalyzed acylation of steroidal tertiary alcohols
DE2817988A1 (de) * 1978-04-25 1979-11-08 Hoechst Ag Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
US4336200A (en) * 1980-01-31 1982-06-22 The Upjohn Company 17α-Acyloxy-5β-corticoids
DE3260474D1 (en) * 1981-02-02 1984-09-06 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
IT1194178B (it) * 1983-03-29 1988-09-14 Ricerche Steroidi Sirs Spa Soc Processo per la preparazione di 17-esteri di clobetasolo e composti ottenuti
ES2078175B1 (es) * 1993-12-31 1996-10-16 Cusi Lab Formulacion farmaceutica conteniendo clobetasona y tobramicina y sus aplicaciones.
US20090304603A1 (en) * 2001-06-15 2009-12-10 Cuticeuticals, Inc. Topical steroid spray with botanic seed oils
US20040022741A1 (en) * 2001-06-15 2004-02-05 Crutchfield Charles E. Topical steroid spray
AR045536A1 (es) * 2003-08-29 2005-11-02 Ranbaxy Lab Ltd Inhibidores de la fosfodiesterasa tipo -iv
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
WO2007031838A1 (en) 2005-09-16 2007-03-22 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
WO2007045979A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
AU2006305620A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
KR20090069309A (ko) * 2006-09-22 2009-06-30 랜박시 래보러터리스 리미티드 포스포디에스터라제 타입-ⅳ의 저해제
EP2066661A2 (en) * 2006-09-22 2009-06-10 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
EP2124943A1 (en) * 2007-03-14 2009-12-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b]pyridine derivatives as phosphodiesterase inhibitors
MX2009009793A (es) 2007-03-14 2009-10-16 Ranbaxy Lab Ltd Derivados de pirazolo (3,4-b) piridina como inhibidores de fosfodiesterasa.
US8796248B2 (en) 2007-10-05 2014-08-05 Nektar Therapeutics Oligomer-corticosteroid conjugates
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
CN101812107B (zh) * 2010-04-20 2013-05-01 浙江仙居仙乐药业有限公司 一种合成丙酸氯倍他索的方法
US8900626B2 (en) 2011-06-20 2014-12-02 Senju Usa, Inc. Transdermal drug delivery system and method of using the same

Also Published As

Publication number Publication date
NL6900795A (xx) 1969-07-22
DE1902340A1 (de) 1969-09-11
DE1902340B2 (de) 1977-06-08
FR2000443A1 (xx) 1969-09-05
DK126500B (da) 1973-07-23
BE727109A (xx) 1969-07-22
IE33204L (en) 1969-07-19
BR6905681D0 (pt) 1973-02-08
CA952900A (en) 1974-08-13
NO132100C (xx) 1975-09-17
ES362679A1 (es) 1971-02-01
US3721687A (en) 1973-03-20
NO132100B (xx) 1975-06-09
IE33204B1 (en) 1974-04-17
CH564035A5 (xx) 1975-07-15
SE350035B (xx) 1972-10-16
IL31447A0 (en) 1969-03-27
IL31447A (en) 1973-11-28
GB1253831A (en) 1971-11-17

Similar Documents

Publication Publication Date Title
AU428130B2 (xx)
AU2374870A (xx)
AU5184069A (xx)
AU6168869A (xx)
AU6171569A (xx)
AU429879B2 (xx)
AU416157B2 (xx)
AU2581067A (xx)
AU4811568A (xx)
AU421558B1 (xx)
AU3789668A (xx)
AU4744468A (xx)
AU2580267A (xx)
AU479393A (xx)
BE642636A (xx)
AU4464266A (xx)
AU4503667A (xx)
AU4558658A (xx)
AU463027A (xx)
AU4270368A (xx)
BE728720A (xx)
AU479894A (xx)
AU4224469A (xx)
BE727109A (xx)
AU3083868A (xx)

Legal Events

Date Code Title Description
PFA Name/firm changed

Owner name: GLAXO OPERATIONS UK LIMITED

PL Patent ceased